Intended for healthcare professionals

Letters Screening for hepatitis C

Early diagnosis and treatment: the goal of hepatitis C screening

BMJ 2015; 350 doi: (Published 24 February 2015) Cite this as: BMJ 2015;350:h635
  1. Nowlan Selvapatt, clinical research fellow1,
  2. Ashley Brown, consultant of hepatology1,
  3. Mark Thursz, professor of hepatology1
  1. 1Department of Hepatology, Imperial College, St Mary’s Hospital, London W2 1NY, UK
  1. nowlan.selvapatt{at}

Koretz and colleagues correctly highlight the need for robust evidence for hepatitis C screening, but a few points warrant a more balanced discussion.1

The impact of hepatitis C should not be underestimated. Deaths associated with hepatitis C trebled in the UK between 1996 and 2010. By 2020, an estimated 15 480 infected people in the UK will have associated cirrhosis or hepatocellular carcinoma.2

The US birth cohort screening programme …

View Full Text

Log in

Log in through your institution


* For online subscription